Connect with us

Health and Lifestyle

Anyakora’s Pharmacity and Nigeria’s Pharma Future -By Patrick Iwelunmor

The urgency of this argument is sharpened when placed against recent disruptions. The COVID-19 pandemic did not create Nigeria’s pharmaceutical vulnerabilities; it revealed them in real time. Global supply chains tightened, imports became uncertain, and foreign exchange volatility turned procurement planning into speculation. Medicines that were assumed to be available became unpredictable, and in that moment, dependence stopped being a policy concern and became a lived vulnerability.

Published

on

Pharmacy

There is a familiar rhythm to how we talk about Nigeria’s pharmaceutical industry. We gather in conference halls, speak with urgency, nod in agreement, and for a moment, it feels like something is about to shift. Then the conversations end, the lights dim, and we return to a system that remains stubbornly unchanged. It is within that cycle that Professor Chimezie Anyakora’s intervention begins to feel less like another policy contribution and more like a quiet refusal to keep pretending that structure and outcome are not fundamentally misaligned. At the 3rd Pharma West Africa Conference in Lagos, his keynote, Building Regional Manufacturing Hubs and Incentives for Local Production, did not arrive with theatrical force but with clarity, the kind that unsettles precisely because it removes the comfort of ambiguity and forces a closer look at what has long been normalised.

His “Pharmacity” concept, an integrated pharmaceutical estate housing 20 to 50 companies within a shared ecosystem of infrastructure, regulation, logistics, and research, is not simply an industrial design proposal; it is an indictment of fragmentation disguised as structure. It exposes a system in which each manufacturer is forced to independently solve the same problems—power generation on an unstable grid, laboratory setup in a capital-intensive environment, compliance navigation across multiple regulatory touchpoints, logistics in a strained supply chain—as though repetition were efficiency rather than a duplication of burden. The argument is unsettling in its simplicity: what we call industry resilience may in fact be institutionalised inefficiency.

And the consequences of that inefficiency are not abstract. They move quietly into everyday life, into pharmacies where essential medicines are intermittently available, into hospital wards where substitutions are made not on clinical preference but on supply realities, into homes where treatment decisions are shaped by cost and access rather than certainty. Nigeria still depends heavily on imported medicines despite having over a hundred registered pharmaceutical manufacturers, a contradiction that has become so routine it risks being mistaken for inevitability. But normalisation does not erase fragility; it merely hides it until disruption exposes it again.

This is where Anyakora’s broader body of work becomes essential to understanding the weight of his argument. Through Bloom Public Health, his interventions have consistently focused on the less visible architecture of the health system—particularly pharmaceutical quality assurance, supply chain integrity, and the persistent gaps that allow substandard and falsified medicines to circulate. These are not peripheral concerns; they are direct consequences of fragmentation. When oversight is dispersed, when testing capacity is uneven, when regulatory enforcement is stretched across distance and delay, quality becomes inconsistent by design rather than by exception. Pharmacity, in this sense, is not only about industrial clustering; it is about compressing the space in which failure can occur.

His presentation at the conference made this connection more explicit by situating manufacturing within a shared infrastructure logic. In his framing, integrated hubs would bring manufacturers, regulators, researchers, logistics providers, and service firms into a single coordinated environment where compliance is not episodic but continuous, and where quality assurance is not outsourced but embedded. Shared laboratories would replace duplicated investment across firms; centralised utilities would reduce operational fragmentation; and proximity to regulators would shorten the distance between production and oversight. The implication is not merely efficiency but transformation in how trust is produced within the system.

Advertisement

The urgency of this argument is sharpened when placed against recent disruptions. The COVID-19 pandemic did not create Nigeria’s pharmaceutical vulnerabilities; it revealed them in real time. Global supply chains tightened, imports became uncertain, and foreign exchange volatility turned procurement planning into speculation. Medicines that were assumed to be available became unpredictable, and in that moment, dependence stopped being a policy concern and became a lived vulnerability. What followed was not a temporary disruption but a sustained reminder that access to essential medicines cannot be outsourced without consequence.

Yet the deeper tension is that Nigeria is not without capacity. There are more than a hundred registered manufacturers, technical expertise exists, and policy discourse increasingly acknowledges the need for self-sufficiency. The problem is not absence but dispersion. Capacity exists in fragments that do not reinforce one another, producing effort without consolidation and activity without systemic strength. This is why the hub model carries weight beyond infrastructure design; it is an attempt to convert scattered capability into coordinated capacity.

Even the policy implications reflect this need for alignment. Incentives in isolation—tax reliefs, foreign exchange access, duty waivers, regulatory streamlining—do not produce structural change unless they operate as a coherent system. Anyakora’s argument, consistent across his engagements, is that industrial transformation requires policy synchronisation rather than policy accumulation. Without that coherence, each intervention becomes a layer added to an unchanged foundation.

There is also a broader economic horizon embedded in his intervention. The African Continental Free Trade Area is often framed as an opportunity for expansion, but expansion without competitiveness is limited in effect. For Nigeria to participate meaningfully as a producer rather than a consumer within that framework, it must be able to manufacture at scale, at consistent quality, and at competitive cost. That transition cannot be achieved through incremental improvement alone; it requires structural reconfiguration of how production itself is organised.

What makes this conversation difficult is not a lack of awareness but the inertia of familiarity. The current system persists not because it is optimal, but because it is known. It is a system that has normalised inefficiency to the point where endurance is mistaken for progress. Anyakora’s intervention disrupts that comfort by reframing what is often treated as a technical challenge into a structural one, and what is treated as structural into something closer to design failure.

Advertisement

In the end, his argument is not simply about pharmaceutical manufacturing. It is about whether Nigeria is willing to move from a system that merely copes to one deliberately constructed to function. The distinction matters because coping is what remains when design has been deferred for too long, and what has been deferred in this case is not another policy adjustment but a fundamental reorganisation of how an industry holds itself together.

Continue Reading
Advertisement
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Trending Contents

Topical Issues

quality-nigerian-flag-for-sale-in-lagos quality-nigerian-flag-for-sale-in-lagos
Breaking News2 days ago

Nigeria, Russia Strengthen Customs Ties with New Trade Cooperation Agreement

The Nigeria Customs Service and Russia's Federal Customs Service agree to deepen trade cooperation, exchange intelligence and improve cargo movement.

Jeff Okoroafor new photo Jeff Okoroafor new photo
Politics2 days ago

Soludo’s Billboard Crackdown: Fear, Not Law, In Anambra -By Jeff Okoroafor

These actions constitute a fundamental betrayal of democratic principles. As the Coalition of South East Youth Leaders (COSEYL) rightly noted,...

Breaking News2 days ago

Peter Obi’s Image Not Reason Umeh’s Billboard Was Removed, Anambra Govt Insists

Anambra Government denies removing Victor Umeh's billboard because it featured Peter Obi, citing alleged non-compliance with signage laws.

Tinubu and Soludo Tinubu and Soludo
Breaking News2 days ago

2027: Soludo Predicts Tinubu’s Victory, Says President Has No Need to Rig Election

Chukwuma Soludo predicts Tinubu's victory in 2027, claiming the APC has stronger nationwide support and no credible opposition alternative.

Ex-President-Goodluck-Jonathan Ex-President-Goodluck-Jonathan
Breaking News2 days ago

Jonathan Reveals Why He Had No Problem Handing Over Power to Buhari

Goodluck Jonathan reveals why handing over power to late President Muhammadu Buhari was easy, describing him as a statesman who...

Adams Oshiomhole Adams Oshiomhole
Breaking News2 days ago

2027: Oshiomhole Insists Igbo President Must Serve Eight Years, Rejects ‘Half Cup’

Senator Adams Oshiomhole says the South-East must not accept a truncated presidential tenure, insisting an Igbo president deserves eight full...

Legal law gavel Legal law gavel
Breaking News3 days ago

N22m Hilux Theft: Bayelsa Court Jails 39-Year-Old Driver for Five Years

Perelayefa Nelson has been jailed for five years after a Bayelsa court convicted him over his involvement in the disappearance...

Uba Sani Uba Sani
Breaking News3 days ago

‘We Have All Failed the People’: Uba Sani Challenges Northern Leaders to Account for Region’s Decline

Uba Sani challenges past and present northern leaders to embrace accountability, reject ethnic politics and develop a common agenda ahead...

European Commission European Commission
Breaking News3 days ago

Ukraine: EU Seeks €45bn Loan as Russian War Deepens Kyiv’s Budget Crisis

European Commission President Ursula von der Leyen says a proposed €45bn loan would strengthen Ukraine’s position at the negotiation table.

Abaribe Abaribe
Breaking News3 days ago

Abaribe Laments Leadership Deficit in Nigeria, Says Country Needs Azikiwe’s Vision

At the 14th Zik Lecture Series, Abaribe praises Azikiwe's leadership philosophy and calls for purposeful governance in Nigeria.